Lethé B, van der Bruggen P, Brasseur F, Boon T
Ludwig Institute for Cancer Research, Brussels Branch, Université Catholique de Louvian, Bruxelles, Belgium.
Melanoma Res. 1997 Aug;7 Suppl 2:S83-8.
Human gene MAGE-1 codes for an antigen that is recognized on a melanoma by an autologous cytotoxic T lymphocyte (CTL). Because MAGE-1 is expressed on a significant proportion of tumours of various histological types and not on normal tissues, the encoded antigen may serve as a target for cancer immunotherapy. Evaluation of the expression of the gene by reverse transcription polymerase chain reaction (RT-PCR) in various tumour samples and tumour cell lines has suggested great variability in the level of expression. It was therefore important to evaluate the minimal level of expression required for lysis by CTL. We tested a number of melanoma cell lines by a quantitative RT-PCR assay to correlate their level of MAGE-1 expression and recognition by the relevant CTL clone. We found that only cell lines expressing more than 10% of the MAGE-1 messenger RNA (mRNA) level of reference cell line MZ2-MEL.3.0 (i.e. more than three mRNA molecules per cell) were lysed by the CTL or induced significant tumour necrosis factor release.
人类基因MAGE-1编码一种抗原,该抗原可被自体细胞毒性T淋巴细胞(CTL)识别为黑色素瘤上的抗原。由于MAGE-1在相当比例的各种组织学类型的肿瘤中表达,而在正常组织中不表达,因此编码的抗原可作为癌症免疫治疗的靶点。通过逆转录聚合酶链反应(RT-PCR)评估该基因在各种肿瘤样本和肿瘤细胞系中的表达,结果表明表达水平存在很大差异。因此,评估CTL裂解所需的最低表达水平非常重要。我们通过定量RT-PCR测定法测试了许多黑色素瘤细胞系,以关联它们的MAGE-1表达水平和相关CTL克隆的识别情况。我们发现,只有那些表达量超过参考细胞系MZ2-MEL.3.0的MAGE-1信使核糖核酸(mRNA)水平10%的细胞系(即每个细胞超过三个mRNA分子)才会被CTL裂解或诱导显著的肿瘤坏死因子释放。